Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-050503
Filing Date
2012-10-24
Accepted
2012-10-24 20:04:03
Documents
1
Period of Report
2012-10-22

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c30300_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c30300_4x0.xml 4 5861
  Complete submission text file 0001209191-12-050503.txt   7567
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address
ZABRISKIE JOHN L (Reporting) CIK: 0001128329 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 121159855
SIC: 2834 Pharmaceutical Preparations